140 related articles for article (PubMed ID: 24477050)
1. The quality of oral anticoagulation in general practice in patients with atrial fibrillation.
Mueller S; Pfannkuche M; Breithardt G; Bauersachs R; Maywald U; Kohlmann T; Wilke T
Eur J Intern Med; 2014 Mar; 25(3):247-54. PubMed ID: 24477050
[TBL] [Abstract][Full Text] [Related]
2. Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients.
Wilke T; Groth A; Mueller S; Pfannkuche M; Verheyen F; Linder R; Maywald U; Kohlmann T; Feng YS; Breithardt G; Bauersachs R
Thromb Haemost; 2012 Jun; 107(6):1053-65. PubMed ID: 22398417
[TBL] [Abstract][Full Text] [Related]
3. Differences in the quality of oral anticoagulation therapy with vitamin K antagonists in German GP practices - results of the cluster-randomized PICANT trial (Primary Care Management for Optimized Antithrombotic Treatment).
Mertens C; Siebenhofer A; Berghold A; Pregartner G; Ulrich LR; Mergenthal K; Kemperdick B; Schulz-Rothe S; Rauck S; Harder S; Gerlach FM; Petersen JJ
BMC Health Serv Res; 2019 Aug; 19(1):539. PubMed ID: 31370840
[TBL] [Abstract][Full Text] [Related]
4. Quality of oral anticoagulation with vitamin K antagonists in 'real-world' patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry.
Esteve-Pastor MA; Rivera-Caravaca JM; Roldán-Rabadán I; Roldán V; Muñiz J; Raña-Míguez P; Ruiz-Ortiz M; Cequier Á; Bertomeu-Martínez V; Badimón L; Anguita M; Lip GYH; Marín F;
Europace; 2018 Sep; 20(9):1435-1441. PubMed ID: 29095971
[TBL] [Abstract][Full Text] [Related]
5. [Management of thromboembolic risk in patients with atrial fibrillation in Italy: baseline data from the PREFER in AF European Registry].
De Caterina R; Renda G; Sangiuolo R; Attena E; Di Lecce L; Romeo F;
G Ital Cardiol (Rome); 2014 Feb; 15(2):99-109. PubMed ID: 24625849
[TBL] [Abstract][Full Text] [Related]
6. [Anticoagulation in high thromboembolic risk after catheter ablation for atrial fibrillation: results from the German Ablation Registry].
Moser J; Kuck KH; Andresen D; Spitzer SG; Hoffmann E; Schumacher B; Eckardt L; Brachmann J; Lewalter T; Hochadel M; Senges J; Willems S; Hoffmann BA
Dtsch Med Wochenschr; 2014 Sep; 139(39):1923-8. PubMed ID: 25225860
[TBL] [Abstract][Full Text] [Related]
7. Quality of anticoagulation with warfarin in patients with nonvalvular atrial fibrillation in the community setting.
Han SY; Palmeri ST; Broderick SH; Hasselblad V; Rendall D; Stevens S; Tenaglia A; Velazquez E; Whellan D; Wagner G; Heitner JF
J Electrocardiol; 2013; 46(1):45-50. PubMed ID: 23063241
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulation in "real world" patients with atrial fibrillation in Italy: results from the ISPAF (Indagine Sicoa Paziente Con Fibrillazione Atriale) survey study.
Volterrani M; Iellamo F; Rosano G; Guarini P; Pusineri E; Bonassi S; Chimini C; Zaccà F; Proto C;
Int J Cardiol; 2013 Oct; 168(5):4729-33. PubMed ID: 23948115
[TBL] [Abstract][Full Text] [Related]
9. Adherence and quality of oral anticoagulation in cerebrovascular disease patients with atrial fibrillation.
Weimar C; Benemann J; Katsarava Z; Weber R; Diener HC
Eur Neurol; 2008; 60(3):142-8. PubMed ID: 18628633
[TBL] [Abstract][Full Text] [Related]
10. Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range.
Connolly SJ; Pogue J; Eikelboom J; Flaker G; Commerford P; Franzosi MG; Healey JS; Yusuf S;
Circulation; 2008 Nov; 118(20):2029-37. PubMed ID: 18955670
[TBL] [Abstract][Full Text] [Related]
11. Reasons underlying non-adherence to and discontinuation of anticoagulation in secondary stroke prevention among patients with atrial fibrillation.
Gumbinger C; Holstein T; Stock C; Rizos T; Horstmann S; Veltkamp R
Eur Neurol; 2015; 73(3-4):184-91. PubMed ID: 25633474
[TBL] [Abstract][Full Text] [Related]
12. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
[TBL] [Abstract][Full Text] [Related]
13. Do anticoagulation management services improve care? Implications of the Managing Anticoagulation Services Trial.
Matchar DB
Card Electrophysiol Rev; 2003 Dec; 7(4):379-81. PubMed ID: 15071259
[TBL] [Abstract][Full Text] [Related]
14. Vitamin K antagonists in patients with nonvalvular atrial fibrillation: appropriateness and quality of treatment in an Italian cohort.
Pereira de Sousa L; Burba I; Ruperto C; Lattuada L; Barbone F; Di Chiara A
J Cardiovasc Med (Hagerstown); 2013 Jul; 14(7):534-40. PubMed ID: 23328227
[TBL] [Abstract][Full Text] [Related]
15. Is the time in therapeutic range using the ratio of tests equivalent to the Rosendaal method?
Caldeira D; Cruz I; Morgado G; Stuart B; Gomes AC; Martins C; João I; Pereira H
Blood Coagul Fibrinolysis; 2015 Dec; 26(8):972-6. PubMed ID: 26083988
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score.
Apostolakis S; Sullivan RM; Olshansky B; Lip GYH
Chest; 2013 Nov; 144(5):1555-1563. PubMed ID: 23669885
[TBL] [Abstract][Full Text] [Related]
18. Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial.
Van Spall HG; Wallentin L; Yusuf S; Eikelboom JW; Nieuwlaat R; Yang S; Kabali C; Reilly PA; Ezekowitz MD; Connolly SJ
Circulation; 2012 Nov; 126(19):2309-16. PubMed ID: 23027801
[TBL] [Abstract][Full Text] [Related]
19. Quality of oral anticoagulation with phenprocoumon in regular medical care and its potential for improvement in a telemedicine-based coagulation service--results from the prospective, multi-center, observational cohort study thrombEVAL.
Prochaska JH; Göbel S; Keller K; Coldewey M; Ullmann A; Lamparter H; Jünger C; Al-Bayati Z; Baer C; Walter U; Bickel C; ten Cate H; Münzel T; Wild PS
BMC Med; 2015 Jan; 13():14. PubMed ID: 25616558
[TBL] [Abstract][Full Text] [Related]
20. Striking a balance between the risks and benefits of anticoagulation bridge therapy in patients with atrial fibrillation: clinical updates and remaining controversies.
Garwood CL; Hwang JM; Moser LR
Pharmacotherapy; 2011 Dec; 31(12):1208-20. PubMed ID: 22122182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
